非转移性前列腺癌男性诊断时共病疾病负担与更高肿瘤分级的相关性
该观察性队列研究纳入1998至2004年两家退伍军人医疗中心1260例新诊断非转移性前列腺癌男性,采用多变量有序和多分类逻辑回归评估Charlson共病指数评分与活检Gleason评分的关系。结果显示Charlson评分2分和3分以上者更高Gleason评分的比值比均升高,且对Gleason 8-10的预测强于Gleason 7。
要点
- Charlson评分2分和3分以上者更高Gleason评分的比值比均为1.8,P<0.001。
- 预测Gleason 7 vs ≤6时,仅Charlson评分2分者比值比为1.6,P=0.01。
- 预测Gleason 8-10 vs ≤6时,Charlson评分1、2、3分以上者比值比分别为1.6、2.8、2.9。
核心结论
- 诊断时中度至重度共病疾病负担可能与高肿瘤分级相关,且独立于年龄,对Gleason 8-10的预测强于Gleason 7。
研究设计与样本
- 观察性队列研究,纳入1998至2004年两家退伍军人医疗中心1260例新诊断非转移性前列腺癌男性。
- 采用多变量有序和多分类逻辑回归评估Charlson共病指数评分与活检Gleason评分的关联。
主要发现
- 与Charlson评分0分者相比,评分2分者更高Gleason评分的OR为1.8(P<0.001),评分3分以上者OR为1.8(P<0.001)。
- 预测Gleason 7 vs ≤6时,与Charlson评分0分者相比,仅评分2分者Gleason 7肿瘤的OR为1.6(P=0.01)。
- 预测Gleason 8-10 vs ≤6时,与Charlson评分0分者相比,评分1分者OR为1.6(P=0.047),评分2分者OR为2.8(P=0.01),评分3分以上者OR为2.9(P=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While older age is associated with higher tumor grade, it is unknown whether comorbid disease burden has a similar, independent association. We sought to evaluate the impact of comorbid disease burden on tumor grade at diagnosis as indicated by biopsy Gleason score. METHODS: We conducted an observational cohort study of 1260 men newly diagnosed with non-metastatic prostate cancer from 1998 to 2004 at two Veterans Affairs Medical Centers. Multivariable ordinal and multinomial logistic regression were used to evaluate the association between Charlson Comorbidity Index score and biopsy Gleason score. RESULTS: Men with Charlson scores of 2 (odds ratio (OR) 1.8, P<0.001) and 3+ (OR 1.8, P<0.001) had significantly greater odds of higher Gleason scores, compared with men with Charlson scores of 0. In a multinomial logistic regression model predicting Gleason 7 vs ⩾6, only men with Charlson scores of 2 (OR 1.6, P=0.01) had greater odds of having a Gleason 7 tumor, compared with those with Charlson scores of 0. In a multinomial logistic regression model predicting Gleason 8-10 vs ⩽6, those with Charlson scores of 1 (OR 1.6, P=0.047), 2 (OR 2.8, P=0.01) and 3+ (OR 2.9, P=0.001) had higher odds of having a Gleason 8-10 tumor. CONCLUSIONS: Moderate-to-heavy comorbid disease burden at diagnosis may be associated with high tumor grade, independent of age, and is a stronger predictor of Gleason 8-10 than Gleason 7 disease.
引用
- Daskivich TJ, Dru CJ, Skarecky D, et al. Association of comorbid disease burden at diagnosis with higher tumor grade in men with non-metastatic prostate cancer. Prostate Cancer Prostatic Dis. 2017. PMID: 28440321. doi:10.1038/pcan.2017.22
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。